Cerity Partners’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,613
Closed -$345K 3360
2025
Q4
$345K Buy
7,613
+354
+5% +$13K ﹤0.01% 2323
2025
Q3
$221K Buy
7,259
+87
+1% +$2.67K ﹤0.01% 2450
2025
Q2
$211K Buy
+7,172
New +$215K ﹤0.01% 2323
2025
Q1
Sell
-6,064
Closed -$268K 2578
2024
Q4
$268K Sell
6,064
-1,109
-15% -$49.8K ﹤0.01% 2094
2024
Q3
$313K Buy
+7,173
New +$270K ﹤0.01% 2023
2022
Q3
Sell
-1,925
Closed -$219K 1235
2022
Q2
$219K Buy
1,925
+235
+14% +$27K ﹤0.01% 1046
2022
Q1
$219K Sell
1,690
-173
-9% -$24.9K ﹤0.01% 840
2021
Q4
$337K Buy
1,863
+157
+9% +$27.2K 0.01% 731
2021
Q3
$253K Buy
1,706
+44
+3% +$6.74K 0.01% 599
2021
Q2
$252K Buy
1,662
+36
+2% +$5.01K 0.01% 632
2021
Q1
$211K Buy
+1,626
New +$209K 0.01% 648

Other funds holding OMCL

Cerity Partners's OMCL Position: Q1 2026 in Review

Cerity Partners sold out of Omnicell (OMCL) in Q1 2026, closing a stake of 7,613 shares — an estimated $345K sold.

Cerity Partners first reported a position in OMCL in Q1 2021 and held it in 11 quarters. The position peaked at $345K in Q4 2025. 273 funds tracked by Wall St. Rank hold OMCL as of Q1 2026.

  • Cerity Partners reported no remaining Omnicell position as of Q1 2026 after selling out during the quarter.
  • Cerity Partners sold 7,613 Omnicell shares in Q1 2026, an estimated $345K.
  • Cerity Partners first reported a position in Omnicell in Q1 2021 and held it in 11 quarters.
  • Cerity Partners's Omnicell position peaked at $345K in Q4 2025.
  • 273 funds tracked by Wall St. Rank held Omnicell as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.